Prelude Therapeutics Stock Price Prediction

Intrinsic Valuation Low Real High 0.10 2.08 10.55 Details

Naive Forecast Low Next High 0.03 1.31 9.78 Details

5 Analysts Consensus Low Target High 4.55 5.00 5.55 Details

Earnings Estimates (0) Low Projected EPS High -0.45 -0.44 -0.44 Details

Prelude Therapeutics After-Hype Price Prediction Density Analysis

Prelude Therapeutics Estimiated After-Hype Price Volatility

Prelude Therapeutics Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.29	8.47	0.01	0.00	6 Events / Month	14 Events / Month	In about 6 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
1.19	1.18	0.84	28,233   Notes

Prelude Therapeutics Hype Timeline

Prelude Therapeutics is at this time traded for 1.19. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. Prelude is expected to decline in value after the next headline, with the price expected to drop to 1.18. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.84%, whereas the daily expected return is at this time at 0.29%. The volatility of related hype on Prelude Therapeutics is about 64372.0%, with the expected price after the next announcement by competition of 1.19. About 85.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Prelude Therapeutics recorded a loss per share of 1.77. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 6 days. Check out Prelude Therapeutics Basic Forecasting Models to cross-verify your projections. For information on how to trade Prelude Stock refer to our How to Trade Prelude Stock guide.

Prelude Therapeutics Related Hype Analysis

Prelude Therapeutics Additional Predictive Modules

Most predictive techniques to examine Prelude price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Prelude using various technical indicators. When you analyze Prelude charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Prelude Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Prelude Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Prelude Therapeutics based on analysis of Prelude Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Prelude Therapeutics depends on current market conditions and Prelude Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Prelude Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Prelude Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Prelude Therapeutics' future price predictability will typically decrease when Prelude Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Prelude Therapeutics often depends not only on the future outlook of the potential Prelude Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Prelude Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.

When running Prelude Therapeutics' price analysis, check to measure Prelude Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prelude Therapeutics is operating at the current time. Most of Prelude Therapeutics' value examination focuses on studying past and present price action to predict the probability of Prelude Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prelude Therapeutics' price. Additionally, you may evaluate how the addition of Prelude Therapeutics to your portfolios can decrease your overall portfolio volatility.